THANKS CM First time trying it, no complaints
Key Areas of Research: Endocrine: Growth hormone, IGF-1, signaling Metabolic: Lipids, lean tissue, glucose balance Cellular: Proliferation, repair, recovery Systemic: Cardiovascular, viability, healing Together, these findings suggest broad experimental potential for CJC-1295 and Ipamorelin across multiple biological pathways
In January 2023, Pirtobrutinib (Jaypirca) was approved in the USA for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) [1]
Appendix: Sources and Further Reading Primary Scientific Publications Eng J, Kleinman WA, Singh L, Singh G, Raufman JP